Ameriprise’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.5K Sell
48,127
-1,494
-3% -$1.07K ﹤0.01% 3897
2025
Q1
$72.9K Sell
49,621
-515,997
-91% -$759K ﹤0.01% 3881
2024
Q4
$2.51M Sell
565,618
-32,584
-5% -$144K ﹤0.01% 2782
2024
Q3
$2.46M Sell
598,202
-40,125
-6% -$165K ﹤0.01% 2797
2024
Q2
$4.16M Buy
638,327
+25,920
+4% +$169K ﹤0.01% 2444
2024
Q1
$5.33M Sell
612,407
-174,641
-22% -$1.52M ﹤0.01% 2319
2023
Q4
$9M Buy
787,048
+74,057
+10% +$847K ﹤0.01% 1876
2023
Q3
$6.87M Buy
712,991
+118,367
+20% +$1.14M ﹤0.01% 2031
2023
Q2
$6.33M Sell
594,624
-36,643
-6% -$390K ﹤0.01% 2163
2023
Q1
$6.64M Buy
631,267
+24,127
+4% +$254K ﹤0.01% 2107
2022
Q4
$7.52M Buy
607,140
+31,574
+5% +$391K ﹤0.01% 1991
2022
Q3
$5.96M Sell
575,566
-37,455
-6% -$388K ﹤0.01% 2081
2022
Q2
$7.07M Buy
613,021
+583,941
+2,008% +$6.73M ﹤0.01% 2026
2022
Q1
$365K Sell
29,080
-7,675
-21% -$96.3K ﹤0.01% 3579
2021
Q4
$429K Sell
36,755
-28,078
-43% -$328K ﹤0.01% 3566
2021
Q3
$846K Buy
64,833
+29,148
+82% +$380K ﹤0.01% 3229
2021
Q2
$459K Sell
35,685
-1,469
-4% -$18.9K ﹤0.01% 3480
2021
Q1
$416K Buy
+37,154
New +$416K ﹤0.01% 3470
2020
Q2
Sell
-59,909
Closed -$605K 3706
2020
Q1
$605K Buy
+59,909
New +$605K ﹤0.01% 3046
2018
Q4
Sell
-12,822
Closed -$199K 3697
2018
Q3
$199K Buy
+12,822
New +$199K ﹤0.01% 3545
2018
Q1
Sell
-89,671
Closed -$1.13M 3646
2017
Q4
$1.13M Sell
89,671
-1,388
-2% -$17.4K ﹤0.01% 2918
2017
Q3
$1.2M Sell
91,059
-2,000
-2% -$26.4K ﹤0.01% 2873
2017
Q2
$1.47M Buy
+93,059
New +$1.47M ﹤0.01% 2753
2014
Q4
Sell
-3,833
Closed -$42K 4058
2014
Q3
$42K Buy
3,833
+442
+13% +$4.84K ﹤0.01% 4083
2014
Q2
$44K Sell
3,391
-2,000
-37% -$26K ﹤0.01% 3952
2014
Q1
$56K Buy
5,391
+96
+2% +$997 ﹤0.01% 3744
2013
Q4
$52K Sell
5,295
-3,523
-40% -$34.6K ﹤0.01% 3645
2013
Q3
$88K Sell
8,818
-633
-7% -$6.32K ﹤0.01% 3521
2013
Q2
$79K Buy
+9,451
New +$79K ﹤0.01% 3480